Search - tctmd.com

Displaying 121 - 140 of 1518

Sort: Relevancy | Date

News Conference News TCT 2024

EARLY TAVR Breaks New Ground for Preemptive Treatment of Asymptomatic AS

L.A. McKeown

October 28, 2024

Presentation TCT 2024

TCT 892: Valvosoft Non-Invasive Ultrasound Therapy (NIUT) in Patients With Severe Symptomatic Aortic Valve Stenosis: Safety and Performance Study, 6-Months Follow-Up Update

Presenter: Helene Eltchaninoff

October 28, 2024

News Conference News TCT 2024

Protecting Coronary Access After TAVI: Valve Choice Clues From CAVEAT

Michael O'Riordan

October 27, 2024

Presentation TCT 2024

TCT 877: Single-Center Experience With Self-Expanding Transcatheter Aortic Valve System for Symptomatic High-Risk Patients With Severe Aortic Regurgitation: One-Year Outcomes

Presenter: Junjie Zhang

October 27, 2024

Presentation TCT 2024

Impact of MitraClip on Hospitalization Rates in Symptomatic Patients With Heart Failure and Moderate to Severe Functional Mitral Regurgitation: Insights From RESHAPE-HF2

Presenter: Ralph von Bardeleben

October 27, 2024

News Daily News

Heart Failure and Cancer: HFSA Statement Explores the Interplay

Caitlin E. Cox

October 24, 2024

News Daily News

SOUL: Oral Semaglutide Cuts CV Events in Diabetic Patients

L.A. McKeown

October 23, 2024

News Opinion Editor's Corner TCT 2024

What’s Going to Be Big at TCT 2024?

Michael O'Riordan

October 17, 2024

News Conference News HFSA 2024

Biomarker and Echo Data Bolster Vutrisiran’s Promise in ATTR-CM

L.A. McKeown

October 04, 2024

News Conference News HFSA 2024

EXPANDed: Atrial Secondary MR Patients Get Clinical Benefit From TEER

Caitlin E. Cox

October 03, 2024

News Conference News HFSA 2024

‘Global Efficacy’ of Aficamten for Obstructive Disease Shown in SEQUOIA-HCM

L.A. McKeown

October 02, 2024

News Conference News HFSA 2024

FINEARTS-HF: New Analyses Ask, Who Benefits Most From Finerenone?

Michael O'Riordan

October 02, 2024

News Daily News

Varipulse Pulsed-Field Ablation System Safe, Effective in Pivotal Trial

Todd Neale

September 30, 2024

News Daily News

Debating a PCI-First Strategy in Stable CAD: ORBITA-2 vs the Unconvinced

Michael O'Riordan

September 20, 2024

News Daily News

Tricuspid TEER Continues to Offer Benefits Through 3 Years: TRILUMINATE

Caitlin E. Cox

September 12, 2024

News Conference News ESC 2024

New ESC Guidelines Merge PAD, Aortic Diseases Into Single Document

Caitlin E. Cox

September 10, 2024

News Conference News ESC 2024

Balloon-Expandable TAVI Superior to SAVR in Women at 1 Year: RHEIA

Caitlin E. Cox

September 04, 2024

News Conference News ESC 2024

SHAM-PVI: Catheter Ablation Improves Objective Measure of AF Burden

Todd Neale

September 02, 2024

News Conference News ESC 2024

MitraClip vs Surgery for Severe FMR? MATTERHORN Claims Noninferiority

Shelley Wood

September 01, 2024

News Conference News ESC 2024

FINEARTS-HF: Benefit of Finerenone Extends to HFmrEF and HFpEF Patients

Michael O'Riordan

September 01, 2024

Advertisement

EARLY TAVR Breaks New Ground for Preemptive Treatment of Asymptomatic AS

TCT 892: Valvosoft Non-Invasive Ultrasound Therapy (NIUT) in Patients With Severe Symptomatic Aortic Valve Stenosis: Safety and Performance Study, 6-Months Follow-Up Update

Protecting Coronary Access After TAVI: Valve Choice Clues From CAVEAT

TCT 877: Single-Center Experience With Self-Expanding Transcatheter Aortic Valve System for Symptomatic High-Risk Patients With Severe Aortic Regurgitation: One-Year Outcomes

Impact of MitraClip on Hospitalization Rates in Symptomatic Patients With Heart Failure and Moderate to Severe Functional Mitral Regurgitation: Insights From RESHAPE-HF2

Heart Failure and Cancer: HFSA Statement Explores the Interplay

SOUL: Oral Semaglutide Cuts CV Events in Diabetic Patients

What’s Going to Be Big at TCT 2024?

Biomarker and Echo Data Bolster Vutrisiran’s Promise in ATTR-CM

EXPANDed: Atrial Secondary MR Patients Get Clinical Benefit From TEER

‘Global Efficacy’ of Aficamten for Obstructive Disease Shown in SEQUOIA-HCM

FINEARTS-HF: New Analyses Ask, Who Benefits Most From Finerenone?

Varipulse Pulsed-Field Ablation System Safe, Effective in Pivotal Trial

Debating a PCI-First Strategy in Stable CAD: ORBITA-2 vs the Unconvinced

Tricuspid TEER Continues to Offer Benefits Through 3 Years: TRILUMINATE

New ESC Guidelines Merge PAD, Aortic Diseases Into Single Document

Balloon-Expandable TAVI Superior to SAVR in Women at 1 Year: RHEIA

SHAM-PVI: Catheter Ablation Improves Objective Measure of AF Burden

MitraClip vs Surgery for Severe FMR? MATTERHORN Claims Noninferiority

FINEARTS-HF: Benefit of Finerenone Extends to HFmrEF and HFpEF Patients

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content